TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATE.
D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002294:Carcinoma, Squamous Cell; D004304:Dosage Forms; D005853:Geriatrics; D006689:Hodgkin Disease; D006801:Humans; D008175:Lung Neoplasms; D009362:Neoplasm Metastasis; D009369:Neoplasms; D011379:Prognosis; D011479:Protamines; D012878:Skin Neoplasms; D013964:Thyroid Neoplasms; D014034:Toes; D014116:Toxicology
D000970:Antineoplastic Agents; D004304:Dosage Forms; D011479:Protamines
ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, EPIDERMOID; DOSAGE FORMS; GERIATRICS; HODGKIN'S DISEASE; LUNG NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; PROTAMINES; SKIN NEOPLASMS; THYROID NEOPLASMS; TOES; TOXICOLOGIC REPORT